Understanding Pharmacokinetic-Drug Interactions With Drugs Approved by the US Food and Drug Administration in 2024 to Better Manage the Risk of Drug Interactions With Concomitant Medications: A Review of Clinical Data From New Drug Applications
Objective: This analysis aimed to provide a mechanistic understanding and an evaluation of the clinical relevance of pharmacokinetic drug-drug interactions (DDIs) associated with drugs approved by the Food and Drug Administration in 2024. Methods: Drug metabolism, transport, and absorption-based DDI...
| Published in: | Current Therapeutic Research |
|---|---|
| Main Authors: | , , , , |
| Format: | Article |
| Language: | English |
| Published: |
Elsevier
2026-06-01
|
| Subjects: | |
| Online Access: | http://www.sciencedirect.com/science/article/pii/S0011393X25000438 |
